NeuroPace (NPCE) Operating Leases (2022 - 2026)

NeuroPace has reported Operating Leases for 5 years, with the latest figure at $10.9 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 15.39% year-over-year to $10.9 million in Q2 2026; TTM through Jun 2026 was $10.9 million, a 15.39% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 17.71% from the prior year.
• Operating Leases was $10.9 million for Q2 2026 at NeuroPace, down from $11.4 million in the prior quarter.
• The five-year high for Operating Leases was $16.5 million in Q1 2023, with the low at $6.2 million in Q2 2022.
• Average Operating Leases over 5 years is $13.0 million, with a median of $13.6 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Leases surged 162.43% in 2023, then dropped 17.71% in 2025.
• Over 5 years, Operating Leases stood at $15.4 million in 2022, then retreated by 10.53% to $13.8 million in 2023, then fell by 13.47% to $12.0 million in 2024, then decreased by 17.71% to $9.8 million in 2025, then grew by 10.99% to $10.9 million in 2026.
• The last three Operating Leases figures came in at $10.9 million (Q2 2026), $11.4 million (Q1 2026), and $9.8 million (Q4 2025), per Business Quant data.